Table 5 |
||||||||||
|
Logistic regression for 5-year radiographic damage according to categories of baseline anti-CCP titer |
||||||||||
|
Anti-CCP titer |
Erosions |
Larsen score ≥ 15 |
||||||||
|
|
||||||||||
|
No with erosions/total in group (%) |
OR (95% CI) |
P value |
Adjusted OR (95% CI)a |
P valuea |
No with Larsen ≥ 15/total in group (%) |
OR (95% CI) |
P value |
Adjusted OR (95% CI)a |
P valuea |
|
|
|
||||||||||
|
≤ 2 |
85/324 (26%) |
Ref |
- |
Ref |
- |
47/323 (15%) |
Ref |
- |
Ref |
- |
|
> 2 to 5 |
14/25 (56%) |
3.6 (1.5, 8.3) |
0.003 |
3.4 (1.2, 9.8) |
0.02 |
11/25 (44%) |
4.6 (1.9, 11) |
0.0001 |
4.3 (1.4, 13) |
0.009 |
|
> 5 to 20 |
16/22 (73%) |
7.5 (2.7, 20) |
< 0.0001 |
3.8 (1.3, 12) |
0.02 |
14/22 (64%) |
10.3 (3.9, 27) |
< 0.0001 |
5.3 (1.7, 16) |
0.003 |
|
> 20 |
94/116 (81%) |
12.4 (6.6, 22) |
< 0.0001 |
9.0 (4.4, 18) |
< 0.0001 |
77/115 (67%) |
11.9 (6.7, 21) |
< 0.0001 |
9.7 (4.7, 20) |
< 0.0001 |
|
|
||||||||||
|
aAdjusted for age, gender, symptom duration and CRP, RF, HAQ, and swollen- and tender-joint counts at baseline. CI, confidence interval; OR, odds ratio. |
||||||||||
|
Burr et al. Arthritis Research & Therapy 2012 14:R109 doi:10.1186/ar3834 |
||||||||||